Previous studies confirmed that glucosamine inhibited the proliferation of human non-small cell lung cancer A549 cells and inhibited the expression of downstream transcription factors FoxO1 and FoxO3 (26). This evidence concerns the gene FOXO1 and non-small cell lung carcinoma.